Agonistic 4-1bb antibodies in combination with inhibitory antibodies against CTLA-4, PD-L1 or LAG-3 ACT on CD8+ T cells in the tumor microenvironment and synergize to promote regression of established tumors
Crossref DOI link: https://doi.org/10.1186/2051-1426-2-S3-P213
Published Online: 2014-11-06
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Horton, Brendan
Spranger, Stefani
Williams, Jason
Gajewski, Thomas
Article History
First Online: 6 November 2014